RHINOCEREBRAL MUCORMYCOSIS DURING DEFEROXAMINE TREATMENT

被引:16
作者
AMMON, A
RUMPF, KW
HOMMERICH, CP
BEHRENSBAUMANN, W
RUCHEL, R
机构
[1] UNIV GOTTINGEN,ZENTRUM INNERE MED,HAMATOL & ONKOL ABT,W-3400 GOTTINGEN,GERMANY
[2] UNIV GOTTINGEN,AUGENHEILKUNDE ABT,W-3400 GOTTINGEN,GERMANY
[3] UNIV GOTTINGEN,HALS NASEN OHREN ABT,W-3400 GOTTINGEN,GERMANY
[4] UNIV GOTTINGEN,MED MIKROBIOL ABT,W-3400 GOTTINGEN,GERMANY
关键词
D O I
10.1055/s-2008-1062461
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A 24-year-old woman had been in full remission of an acute myeloid leukaemia since 1988, but she required regular erythrocyte and platelet transfusions for pancytopenia. To counteract a progressive siderophilia due to the transfusions (ferritin levels of about 10,000 ng/ml) deferoxamine was intermittently given intravenously (5 g after each transfusion). Seven months after the start of this treatment the patient was hospitalized because of severe left-sided facial pain as well as reddening and swelling in the periorbital region. As maxillary and frontal sinusitis was suspected, antibiotics were administered (at first three times daily 2,2 g amoxicillin and clavulanic acid, then two times daily 300 mg rifampicin and 200 mg ciprofloxacin). Nonetheless, orbital phlegmon developed within a few days with protrusion and blindness of the left eye necessitating a decompression operation. Material obtained at operation revealed rhinocerebral mucormycosis. After 3 weeks of antimycotic treatment with both amphotericin B (1 mg/kg.d) and flucytosine (150 mg/kg.d) the mucormycosis healed without the necessity of extensive and disfiguring removal of necrotic tissue. But the blindness in the left eye, caused by occlusion of the central artery, was irreversible.
引用
收藏
页码:1434 / 1438
页数:5
相关论文
共 10 条
[1]   DEFEROXAMINE THERAPY AND MUCORMYCOSIS IN DIALYSIS PATIENTS - REPORT OF AN INTERNATIONAL REGISTRY [J].
BOELAERT, JR ;
FENVES, AZ ;
COBURN, JW .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1991, 18 (06) :660-667
[2]  
BRUSIS T, 1986, HNO, V34, P262
[3]  
DONHUIJSEN K, 1991, SCHWEIZ MED WSCHR, V121, P1493
[4]   RHINOCEREBRAL MUCORMYCOSIS IN ACUTE-LEUKEMIA [J].
FARACK, UM ;
THIEL, E .
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1985, 110 (01) :24-27
[5]  
FEGELER WA, 1987, KLINIK DIAGNOSTIK TH, V1, P7
[6]  
HOLZER E, 1983, 1982 HAHN S, P281
[7]  
RASSE M, 1990, WIEN KLIN WOCHENSCHR, V102, P395
[8]   DEFEROXAMINE TREATMENT AS A RISK FACTOR FOR ZYGOMYCETE INFECTION [J].
SANE, A ;
MANZI, S ;
PERFECT, J ;
HERZBERG, AJ ;
MOORE, JO .
JOURNAL OF INFECTIOUS DISEASES, 1989, 159 (01) :151-152
[9]   FATAL MUCORMYCOSIS THERAPY ASSOCIATED WITH DEFEROXAMINE [J].
SLADE, MP ;
MCNAB, AA .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1991, 112 (05) :594-595
[10]  
SUGAR AM, 1990, PRINCIPLES PRACTICE, P1963